About Pharma Bio Serv (OTCMKTS:PBSV)
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
Industry, Sector and Symbol
Industry Management Services
Trailing P/E Ratio-8.75
Forward P/E Ratio-10.50
Sales & Book Value
Annual Sales$19.54 million
Price / Sales0.62
Price / CashN/A
Book Value$0.95 per share
Price / Book0.55
Return on Equity-6.47%
Return on Assets-6.00%
Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions
What is Pharma Bio Serv's stock symbol?
Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."
How were Pharma Bio Serv's earnings last quarter?
Pharma Bio Serv Inc (OTCMKTS:PBSV) released its earnings results on Thursday, January, 29th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The business had revenue of $7.14 million for the quarter, compared to analyst estimates of $7.09 million. Pharma Bio Serv had a negative return on equity of 6.47% and a negative net margin of 8.33%. View Pharma Bio Serv's Earnings History.
When will Pharma Bio Serv make its next earnings announcement?
Who are some of Pharma Bio Serv's key competitors?
Some companies that are related to Pharma Bio Serv include Pacific Drilling (PACDQ), Innovus Pharmaceuticals (INNV), Critical Outcome T (COTQF), HealthWarehouse.com (HEWA), Windtree Therapeutics (WINT), Sierra Monitor (SRMC), Premier (PRHL), Black Ridge Oil & Gas (ANFC), Acura Pharmaceuticals (ACUR), OMNI-LITE INDS CAN (OLNCF), usell.com (USEL), Deep Down (DPDW), Atna Resources (ATNAQ), Noble Roman's (NROM), Destiny Media Technologies (DSNY), Trxade Group (TRXD), Cool Technologies (WARM) and B456 Systems (AONEQ).
Who are Pharma Bio Serv's key executives?
Pharma Bio Serv's management team includes the folowing people:
- Elizabeth Plaza, Chairman of the Board (Age 52)
- Victor Sanchez, President, Chief Executive Officer (Age 44)
- Pedro J. Lasanta, Chief Financial Officer, Vice President - Finance and Administration, Secretary (Age 55)
- Howard Spindel, Independent Director (Age 72)
- Irving L. Wiesen, Independent Director (Age 60)
How do I buy Pharma Bio Serv stock?
Shares of Pharma Bio Serv can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharma Bio Serv's stock price today?
One share of Pharma Bio Serv stock can currently be purchased for approximately $0.53.
How big of a company is Pharma Bio Serv?
Pharma Bio Serv has a market capitalization of $12.13 million and generates $19.54 million in revenue each year. The company earns $-250,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma Bio Serv employs 185 workers across the globe.
How can I contact Pharma Bio Serv?
Pharma Bio Serv's mailing address is Industrial Zone Street 1, Lot 14, DORADO, 00646, Puerto Rico. The company can be reached via phone at +1-787-2782709 or via email at [email protected]
MarketBeat Community Rating for Pharma Bio Serv (PBSV)MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pharma Bio Serv (OTCMKTS:PBSV) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Pharma Bio Serv (OTCMKTS:PBSV) Earnings History and Estimates Chart
Pharma Bio Serv (OTCMKTS PBSV) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|1/30/2018|| || || || || || || || |
|1/29/2015||$0.03||$0.04||$7.09 million||$7.14 million||View||N/A|
|9/15/2014||$0.02||$0.03||$7.37 million||$6.84 million||View||N/A|
|6/16/2014||$0.05||$0.01||$7.51 million||$6.58 million||View||N/A|
Pharma Bio Serv (OTCMKTS:PBSV) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $0.02 EPS
Dividend History for Pharma Bio Serv (OTCMKTS:PBSV)
No dividend announcements for this company have been tracked by MarketBeat.com
Pharma Bio Serv (OTCMKTS PBSV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 51.20%
Pharma Bio Serv (OTCMKTS PBSV) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/11/2014||Kirk Wheeler Michel||Director||Sell||9,170||$2.06||$18,890.20|| |
Pharma Bio Serv (OTCMKTS PBSV) News Headlines
Pharma Bio Serv (OTCMKTS:PBSV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Pharma Bio Serv (OTCMKTS PBSV) Stock Chart for Tuesday, January, 16, 2018